On April 4, 2022 Janet Church, Sjögren’s Foundation CEO, and Cassandra Calabrese, DO, member of the Foundation’s COVID-19 Vaccination Committee, discussed the current recommendations for the “second booster” of the vaccine. In this video they discuss evolving COVID-19 precautions, the fourth dose vaccine recommendation, and other topics that could impact you as a Sjögren’s patient.
Learn more about:
- Vaccine & booster risk/benefit recommendations
- New medication options for Sjögren’s patients on immunosuppressive drugs such as rituximab
- The new COVID-19 Omicron variant BA.2
- Suggestions about social distancing and masking